Men | Women | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
SHAa | Opioidsb | Other medicaments | No medicaments | Total | SHAa | Opioidsb | Other medicaments | No medicaments | Total | |
Total | 2.1 | 0.9 | 55.8 | 41.2 | 100.0 | 3.5 | 1.5 | 60.6 | 34.4 | 100.0 |
All individuals | Chi2 27.5; df 3; p < 0.001; w .08 | |||||||||
All medicament users | Chi2 6.6; df 2; p <.05; w .05 | |||||||||
Age (years) | ||||||||||
20–39 | 1.5 | 0.5 | 31.5 | 66.5 | 100.0 | 1.0 | 1.1 | 39.9 | 58.0 | 100.0 |
40–59 | 1.0 | 1.2 | 47.7 | 50.1 | 100.0 | 3.0 | 1.7 | 62.6 | 32.8 | 100.0 |
60–79 | 3.8 | 0.9 | 82.7 | 12.6 | 100.0 | 6.8 | 1.6 | 80.3 | 11.3 | 100.0 |
All individuals | Chi2 490.5; df 6; p < 0.001; w .46 | Chi2 367.5; df 6; p < 0.001; w.40 | ||||||||
All medicament users | Chi2 7.7; df 4; ns; w .08 | Chi2 13.7; df 4; p < 0.01; w .10 | ||||||||
Education (years) | ||||||||||
< 10 | 2.9 | 0.8 | 69.6 | 26.7 | 100.0 | 5.8 | 1.8 | 74.4 | 18.0 | 100.0 |
10 | 1.8 | 1.1 | 43.2 | 53.9 | 100.0 | 2.0 | 1.6 | 51.0 | 45.4 | 100.0 |
> 10 | 1.0 | 0.6 | 51.4 | 47.0 | 100.0 | 2.0 | 0.3 | 57.5 | 40.3 | 100.0 |
All individuals | Chi2 149.5; df 6; p < 0.001; w .26 | Chi2 181.1; df 6; p < 0.001; w.28 | ||||||||
All medicament users | Chi2 5.4; df 4; ns; w .07 | Chi2 13.4; df 4; p < 0.01; w .09 |